The Biggest Open Opportunity in Health AI: Building for the Patient Journey, Not the Ticket Queue

About this session

Nearly every health company has shipped an AI agent, and almost all of them built the same thing: a reactive bot that waits for a patient to show up with a problem, answers the question, and closes the chat. It saves a little cost and moves none of the metrics these companies say they care about: retention, engagement, and real outcomes.

That gap is the opportunity. The next wave of health AI is proactive, it re-engages patients before they drop off, remembers every prior interaction, and is pointed at clinical goals, not ticket deflection.

But healthcare raises the bar: outreach only counts if it makes the patient healthier. I'll map where the durable opportunities are across the patient journey, what makes them defensible, and the trap most builders fall into.

Speaker

Key takeaways

  • Why most health AI today is reactive and cost-focused, and where the real, under-served opportunity sits across the patient journey (proactive re-engagement, retention, adherence, outcomes).
  • What makes proactive patient-facing AI defensible: tying engagement to genuine clinical benefit rather than vanity usage metrics, and the safety/quality bar healthcare demands.
  • A practical lens for builders deciding where to build in health AI in 2026, which problems are worth solving, and the failure mode (engagement-for-its-own-sake) to avoid.

Related sessions